Biomedical Optical Coherence Tomography Market by Applications (Dermatology, Ophthalmology, Gastroenterology, Cancer Diagnosis, Intra Surgery for Tumor Margining, and Dentistry) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global biomedical optical coherence tomography market size is estimated to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing global geriatric population, growing cases of skin and neurology based disorders, and high demand for non-radiation imaging modalities.
Biomedical optical coherence tomography (OCT) is a new technique for high-resolution cross-sectional imaging. This technology is similar to ultrasound imaging; however, it employs light as a replacement of sound. In situ and in real time, biomedical OCT can offer cross-sectional images of tissue structure on the micron scale. High-resolution intraluminal imaging of organ systems is possible using biomedical OCT in conjunction with catheters and endoscopes. Furthermore, unlike traditional histopathology, which needs the elimination of a tissue specimen and processing for microscopic analysis; biomedical OCT can operate as a type of optical surgery and is a potent imaging method for medical diagnostics. Moreover, biomedical OCT can produce real-time pictures of tissue in situ. It can be utilized to guide interventional operations and reduce sampling errors associated with excisional biopsy when standard excisional biopsy is dangerous or impracticable.
Due to COVID-19 pandemic outbreak globally, it has impacted various industries in terms of supply chain, import & export control, regional government policies and future course of action. The biomedical optical coherence tomography market is harshly impacted due to this pandemic. However, all major precautions are taken during treatment procedures, followed by prescribed guidelines. Alternatively, patients are encouraged telemedicine consultation for follow-ups, and hospitals & clinics are minimizing the contacts between patients & staffs for the treatment.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing demand for non-invasive medical procedures and rising cases of ophthalmic diseases globally are key factors boosting the market growth.
- High unmet medical needs and ongoing development of healthcare infrastructure in emerging economies are expected to upsurge the market growth in the coming years.
- Ongoing awareness campaign conducted by various public & private organization for eye related disorders and increasing R&D activities for advanced biomedical OCT systems are expected to propel the market growth during the forecast period.
- Absence of medical reimbursement policies and insufficient clinical data are key challenging factors that are expected to hinder the market growth during the forecast period.
- Technologically advanced high-resolution OCT in the fields of dermatology and gastroenterology is expected to offer immense opportunity for the market expansion during the forecast period.
Scope of the Report
The report on the global biomedical optical coherence tomography market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Biomedical Optical Coherence Tomography Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Applications (Dermatology, Ophthalmology, Gastroenterology, Cancer Diagnosis, Intra Surgery for Tumor Margining, and Dentistry) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Heliotis AG; Agfa HealthCare; Carl Zeiss AG; Michelson Diagnostics Ltd.; Meditec AG; and Imalux Corp. |
Market Segment Insights
Ophthalmology segment is projected to expand at a considerable CAGR
Based on applications, the global biomedical optical coherence tomography market is segmented into dermatology, ophthalmology, gastroenterology, cancer diagnosis, intra surgery for tumor margining, and dentistry. The ophthalmology segment is projected to expand at a considerable CAGR during the forecast period owing to the introduction of technological advanced devices with enhanced performance, accurateness, and ease of use along with the augmenting incidences of retinal and choroidal disorders.
However, the dermatology segment is projected to register a high growth rate during the forecast period. Since 1997, the devices have been utilized in dermatology and have undergone significant developments to fulfil the demand for non-invasive imaging and monitoring of various skin conditions.
North America is anticipated to constitute a key market share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period due to the rising investment in R&D activities and growing adoption of the new products. Furthermore, rapid growth of hospitals and laboratory facilities that are resulting in development of new products. For example, Notal Vision has announced the introduction of its first self-operated optical coherence tomography equipment with longitudinal research in the United States in January 2021. Thus, all these factors are expected to increase the market expansion in the region.
However, the quicker processing of approvals and documents required to enable automated devices into the region, Europe is likely to exhibit a high expansion rate of the market in the coming years. For example, the CEA accelerated the distribution of Topcon's latest goods across the European Union, resulting in increasing revenue share for the region.
Segments
The global biomedical optical coherence tomography market has been segmented on the basis of
Applications
- Dermatology
- Ophthalmology
- Gastroenterology
- Cancer Diagnosis
- Intra Surgery for Tumor Margining
- Dentistry
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Heliotis AG
- Agfa HealthCare
- Carl Zeiss AG
- Michelson Diagnostics Ltd.
- Meditec AG
- Imalux Corp.
Competitive Landscape
Some of the key players competing in the global biomedical optical coherence tomography market are Heliotis AG; Agfa HealthCare; Carl Zeiss AG; Michelson Diagnostics Ltd.; Meditec AG; and Imalux Corp. Various marketing strategies such as partnership & collaboration, fund infusion, merger & acquisitions, and new product launch are implemented by these key players to gain substantial market share in the market.
Optovue, for example, has developed high-density OCT angiography for ophthalmology, which provides high-resolution and peripheral vision of the eye's vascular. As a result, product launches and innovation are projected to boost the growth of the biomedical OCT market.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biomedical Optical Coherence Tomography Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biomedical Optical Coherence Tomography Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biomedical Optical Coherence Tomography Market - Supply Chain
4.5. Global Biomedical Optical Coherence Tomography Market Forecast
4.5.1. Biomedical Optical Coherence Tomography Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biomedical Optical Coherence Tomography Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Biomedical Optical Coherence Tomography Market Absolute $ Opportunity
5. Global Biomedical Optical Coherence Tomography Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
5.3.1. Dermatology
5.3.2. Ophthalmology
5.3.3. Gastroenterology
5.3.4. Cancer Diagnosis
5.3.5. Intra Surgery for Tumor Margining
5.3.6. Dentistry
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Biomedical Optical Coherence Tomography Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
7. North America Biomedical Optical Coherence Tomography Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
7.4.1. Dermatology
7.4.2. Ophthalmology
7.4.3. Gastroenterology
7.4.4. Cancer Diagnosis
7.4.5. Intra Surgery for Tumor Margining
7.4.6. Dentistry
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
8. Latin America Biomedical Optical Coherence Tomography Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
8.4.1. Dermatology
8.4.2. Ophthalmology
8.4.3. Gastroenterology
8.4.4. Cancer Diagnosis
8.4.5. Intra Surgery for Tumor Margining
8.4.6. Dentistry
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
9. Europe Biomedical Optical Coherence Tomography Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
9.4.1. Dermatology
9.4.2. Ophthalmology
9.4.3. Gastroenterology
9.4.4. Cancer Diagnosis
9.4.5. Intra Surgery for Tumor Margining
9.4.6. Dentistry
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
10. Asia Pacific Biomedical Optical Coherence Tomography Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
10.4.1. Dermatology
10.4.2. Ophthalmology
10.4.3. Gastroenterology
10.4.4. Cancer Diagnosis
10.4.5. Intra Surgery for Tumor Margining
10.4.6. Dentistry
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
11. Middle East & Africa Biomedical Optical Coherence Tomography Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
11.4.1. Dermatology
11.4.2. Ophthalmology
11.4.3. Gastroenterology
11.4.4. Cancer Diagnosis
11.4.5. Intra Surgery for Tumor Margining
11.4.6. Dentistry
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Biomedical Optical Coherence Tomography Market: Market Share Analysis
12.2. Biomedical Optical Coherence Tomography Distributors and Customers
12.3. Biomedical Optical Coherence Tomography Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Heliotis AG
12.4.2. Agfa HealthCare
12.4.3. Carl Zeiss AG
12.4.4. Michelson Diagnostics Ltd.
12.4.5. Meditec AG
12.4.6. Imalux Corp.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biomedical Optical Coherence Tomography Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biomedical Optical Coherence Tomography Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biomedical Optical Coherence Tomography Market - Supply Chain
4.5. Global Biomedical Optical Coherence Tomography Market Forecast
4.5.1. Biomedical Optical Coherence Tomography Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biomedical Optical Coherence Tomography Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Biomedical Optical Coherence Tomography Market Absolute $ Opportunity
5. Global Biomedical Optical Coherence Tomography Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
5.3.1. Dermatology
5.3.2. Ophthalmology
5.3.3. Gastroenterology
5.3.4. Cancer Diagnosis
5.3.5. Intra Surgery for Tumor Margining
5.3.6. Dentistry
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Biomedical Optical Coherence Tomography Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
7. North America Biomedical Optical Coherence Tomography Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
7.4.1. Dermatology
7.4.2. Ophthalmology
7.4.3. Gastroenterology
7.4.4. Cancer Diagnosis
7.4.5. Intra Surgery for Tumor Margining
7.4.6. Dentistry
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
8. Latin America Biomedical Optical Coherence Tomography Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
8.4.1. Dermatology
8.4.2. Ophthalmology
8.4.3. Gastroenterology
8.4.4. Cancer Diagnosis
8.4.5. Intra Surgery for Tumor Margining
8.4.6. Dentistry
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
9. Europe Biomedical Optical Coherence Tomography Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
9.4.1. Dermatology
9.4.2. Ophthalmology
9.4.3. Gastroenterology
9.4.4. Cancer Diagnosis
9.4.5. Intra Surgery for Tumor Margining
9.4.6. Dentistry
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
10. Asia Pacific Biomedical Optical Coherence Tomography Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
10.4.1. Dermatology
10.4.2. Ophthalmology
10.4.3. Gastroenterology
10.4.4. Cancer Diagnosis
10.4.5. Intra Surgery for Tumor Margining
10.4.6. Dentistry
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
11. Middle East & Africa Biomedical Optical Coherence Tomography Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Biomedical Optical Coherence Tomography Market Size and Volume Forecast by Applications
11.4.1. Dermatology
11.4.2. Ophthalmology
11.4.3. Gastroenterology
11.4.4. Cancer Diagnosis
11.4.5. Intra Surgery for Tumor Margining
11.4.6. Dentistry
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Biomedical Optical Coherence Tomography Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Biomedical Optical Coherence Tomography Market: Market Share Analysis
12.2. Biomedical Optical Coherence Tomography Distributors and Customers
12.3. Biomedical Optical Coherence Tomography Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Heliotis AG
12.4.2. Agfa HealthCare
12.4.3. Carl Zeiss AG
12.4.4. Michelson Diagnostics Ltd.
12.4.5. Meditec AG
12.4.6. Imalux Corp.
The global biomedical optical coherence tomography market has been segmented on the basis of
Applications
- Dermatology
- Ophthalmology
- Gastroenterology
- Cancer Diagnosis
- Intra Surgery for Tumor Margining
- Dentistry
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Heliotis AG
- Agfa HealthCare
- Carl Zeiss AG
- Michelson Diagnostics Ltd.
- Meditec AG
- Imalux Corp.
Some of the key players competing in the global biomedical optical coherence tomography market are Heliotis AG; Agfa HealthCare; Carl Zeiss AG; Michelson Diagnostics Ltd.; Meditec AG; and Imalux Corp. Various marketing strategies such as partnership & collaboration, fund infusion, merger & acquisitions, and new product launch are implemented by these key players to gain substantial market share in the market.
Optovue, for example, has developed high-density OCT angiography for ophthalmology, which provides high-resolution and peripheral vision of the eye's vascular. As a result, product launches and innovation are projected to boost the growth of the biomedical OCT market.
Our Clients
Related Reports
Some other reports from this category!
